NCT05117697 (STCAF) is a NA clinical trial of lateral subcutaneous sphincterotomy in Chronic Anal Fissure, sponsored by State Scientific Centre of Coloproctology, Russian Federation.

Who is sponsoring NCT05117697?

NCT05117697 is sponsored by State Scientific Centre of Coloproctology, Russian Federation.

What drugs are being tested in NCT05117697?

Interventions in NCT05117697: lateral subcutaneous sphincterotomy.

What condition does NCT05117697 study?

NCT05117697 studies Chronic Anal Fissure.

Is NCT05117697 still recruiting?

NCT05117697 is currently status unknown. Last updated 11 November 2021.

Last reviewed 2021-11-11 · How we verify

NCT05117697: STCAF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Treatment of a Chronic Anal Fissure

Status unknown NA Last updated 11 November 2021

What this trial tests

NA trial testing lateral subcutaneous sphincterotomy in Chronic Anal Fissure in 120 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 May 2022

1 May 2023

Quick facts

Lead sponsor	State Scientific Centre of Coloproctology, Russian Federation
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	120
Start date	1 November 2021
Primary completion	1 May 2022
Estimated completion	1 May 2023
Sites	2 locations across Russia

Drugs / interventions tested

lateral subcutaneous sphincterotomy

Conditions studied

Chronic Anal Fissure — all drugs for Chronic Anal Fissure →

Sponsor

State Scientific Centre of Coloproctology, Russian Federation — full company profile →

Who can join

Adults 18 to 70, any sex, with Chronic Anal Fissure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Anal Fissure

Currently open trials in the same condition.

NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting

Other State Scientific Centre of Coloproctology, Russian Federation trials

Trials by the same sponsor.

NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting
NCT05598164 — Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure · NA · unknown
NCT05495776 — Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer · recruiting
NCT05228054 — Treatment of Hemorrhoid With 1940nm Laser Procedure · NA · unknown
NCT04801355 — Full-thickness Laparo-endoscopic Excision vs Laparoscopic Colectomy for Colonic Tumors · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05117697 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State Scientific Centre of Coloproctology, Russian Federation
Last refreshed: 11 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05117697.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing